C07K 14/435
From animals
Official title: from animals; from humans
C07K14/435 (From animals) appears on 53,938 US grants and 75,216 published applications in this corpus.
Search patents in C07K- Granted patents
- 53,938
- Published applications
- 75,216
- Assignees
- 15,553
- Inventors
- 102,504
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 44 | 0 |
| 1977 | 58 | 0 |
| 1978 | 107 | 0 |
| 1979 | 57 | 0 |
| 1980 | 96 | 0 |
| 1981 | 93 | 0 |
| 1982 | 81 | 0 |
| 1983 | 103 | 0 |
| 1984 | 133 | 0 |
| 1985 | 115 | 0 |
| 1986 | 128 | 0 |
| 1987 | 200 | 0 |
| 1988 | 193 | 0 |
| 1989 | 238 | 0 |
| 1990 | 216 | 0 |
| 1991 | 310 | 0 |
| 1992 | 441 | 0 |
| 1993 | 548 | 0 |
| 1994 | 545 | 0 |
| 1995 | 619 | 0 |
| 1996 | 859 | 0 |
| 1997 | 1429 | 0 |
| 1998 | 2168 | 0 |
| 1999 | 2061 | 0 |
| 2000 | 1706 | 0 |
| 2001 | 1741 | 334 |
| 2002 | 1639 | 3127 |
| 2003 | 1495 | 6050 |
| 2004 | 1345 | 3447 |
| 2005 | 1145 | 3244 |
| 2006 | 1688 | 2807 |
| 2007 | 1724 | 2427 |
| 2008 | 1537 | 2283 |
| 2009 | 1481 | 2701 |
| 2010 | 1604 | 2491 |
| 2011 | 1540 | 2352 |
| 2012 | 1404 | 2033 |
| 2013 | 1427 | 2142 |
| 2014 | 1449 | 2228 |
| 2015 | 1492 | 2272 |
| 2016 | 1525 | 2505 |
| 2017 | 1552 | 2370 |
| 2018 | 1532 | 2698 |
| 2019 | 1741 | 3134 |
| 2020 | 1912 | 3361 |
| 2021 | 1942 | 3643 |
| 2022 | 1871 | 3844 |
| 2023 | 1635 | 3680 |
| 2024 | 1809 | 3990 |
| 2025 | 1904 | 3443 |
| 2026 | 1256 | 2610 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods of preparation of pan TLR antagonistic liposomal-LNP formulations and uses thereof6 Oct 2026US 12,751,920 B2Celestial Therapeutics, Inc.
- Methods and compositions for treating cardiovascular diseases using fat specific protein 27 (FSP27) compositions6 Oct 2026US 12,751,992 B2Ohio University
- Compositions, methods and kits for treating complement related disorders6 Oct 2026US 12,751,993 B2Trustees of Tufts College
- Microdystrophin nucleic acid gene therapy constructs and uses thereof6 Oct 2026US 12,752,020 B2REGENXBIO Inc.
- Methods of manufacturing microdystrophin gene therapy constructs6 Oct 2026US 12,752,021 B2REGENXBIO Inc.
- Transgenic model of human cardiomyopathy8 Oct 2026US 2026/0305586 A1Stichting Genetische Hartspierziekte PLN
- System, method, and apparatus for bioinspired strategies for efficient light harvesting and optical processing8 Oct 2026US 2026/0305745 A1Trustees of Tufts College
- Active loading of biomolecular cargo into engineered vesicles8 Oct 2026US 2026/0306415 A1Northwestern University
- Extracellular vesicles for the delivery of payloads to eukaryotic cells8 Oct 2026US 2026/0306416 A1Alaya.bio Inc.
- Application of CCR5hi Innate Immune Memory Cells in Preparation of Immunotherapeutic Drug for Treating Sepsis8 Oct 2026US 2026/0306538 A1Children's Hospital of Soochow University
Most cited
By later US patents
- Directed evolution of novel binding proteins2,450US 5,223,409 AProtein Engineering Corporation · 1993
- Non-immunogenic polypeptides2,007US 4,179,337 A1979
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies1,680US 5,633,425 AGenPharm International, Inc. · 1997